In general, LATS1 plays a critical role in orchestrating the Hippo-YAP1 pathway, thereby subsequently leading to the inhibition of proliferation and invasion in cancer cells [4, 36], indicating that targeting LATS1 could be a promising strategy for GC treatment. This evidence concerns the gene YAP1 and gastric cancer.